Alembic Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹796.95(-1.58%)February 6, 2026 15:25:46 PM IST
- NSE
- BSE
- Vol : 119.28 K (NSE + BSE)Last 20 day avg : 69.59 K
Alembic Pharmaceuticals is trading -1.58% lower at Rs 796.95 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 809.75 & 777.80. Alembic Pharmaceuticals has given -4.22% in this year & 3.48% in the last 5 days. Alembic Pharmaceuticals has TTM P/E ratio 27.90 as compared to the sector P/E of 23.40.There are 12 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 4 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 132.98 Crores in its last quarter.Listed peers of Alembic Pharmaceuticals include Sun Pharmaceutical Industries (-0.43%), Dr Reddy's Laboratories (-0.29%), Divi's Laboratories (-1.78%).The Mutual Fund holding in Alembic Pharmaceuticals was at 8.22% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Alembic Pharmaceuticals was at 4.23% in 31 Dec 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 07, 2026, 05:39 AM UTC
- BetaMedium volatility0.85Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.24The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.36Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation6.52The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Neutral | 1,694.90 | -0.43 | 4,06,653.70 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Neutral | 1,241.60 | -0.29 | 1,03,622.86 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Bearish | 6,027.00 | -1.78 | 1,60,509.28 | 78.61 | 11.52 | 0.46 | 0.01 |
| Cipla | Moderately Bearish | 1,330.80 | -0.14 | 1,07,490.21 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Neutral | 3,931.65 | -1.04 | 1,33,059.55 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
- IndustryBiotechnology & Drugs
- ISININE901L01018
- BSE Code533573
- NSE CodeAPLLTD
Alembic Pharmaceuticals is trading at 796.95 as on Fri Feb 06 2026 09:55:46. This is -1.58% lower as compared to its previous closing price of 809.75.
The market capitalization of Alembic Pharmaceuticals is 15822.39 Cr as on Fri Feb 06 2026 09:55:46.
The average broker rating on Alembic Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 6 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Alembic Pharmaceuticals is 1107.80 whereas the 52 wk low is 725.60
Alembic Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 27.90
- Sector P/E: 23.40
- Dividend Yield: 1.36%
- D/E ratio: 0.28
Alembic Pharmaceuticals reported a net profit of 583.42 Cr in 2025.
The Mutual Fund Shareholding was 8.22% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Alembic Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.